

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adaptation of signaling pathway (GO:0023058) | 9.07038094 |
| 2 | positive regulation of chemokine secretion (GO:0090197) | 8.74823276 |
| 3 | regulation of chemokine secretion (GO:0090196) | 7.56373971 |
| 4 | negative regulation of protein localization to cell surface (GO:2000009) | 7.31635109 |
| 5 | negative regulation of sodium ion transport (GO:0010766) | 7.11641889 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.80591698 |
| 7 | positive regulation of keratinocyte differentiation (GO:0045618) | 6.54082050 |
| 8 | positive regulation of digestive system process (GO:0060456) | 6.50948643 |
| 9 | toxin transport (GO:1901998) | 6.48614623 |
| 10 | negative regulation of systemic arterial blood pressure (GO:0003085) | 6.45158877 |
| 11 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 6.35233312 |
| 12 | regulation of tight junction assembly (GO:2000810) | 6.34819883 |
| 13 | linoleic acid metabolic process (GO:0043651) | 6.23908039 |
| 14 | retinal metabolic process (GO:0042574) | 5.84685710 |
| 15 | plasma membrane repair (GO:0001778) | 5.79540840 |
| 16 | positive regulation of blood pressure (GO:0045777) | 5.66455195 |
| 17 | regulation of endocrine process (GO:0044060) | 5.63585202 |
| 18 | sequestering of extracellular ligand from receptor (GO:0035581) | 5.53427828 |
| 19 | mature B cell differentiation (GO:0002335) | 5.46956437 |
| 20 | cellular response to fatty acid (GO:0071398) | 5.42635490 |
| 21 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 5.23966505 |
| 22 | positive regulation of T cell cytokine production (GO:0002726) | 5.17620648 |
| 23 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.14397447 |
| 24 | lipoxygenase pathway (GO:0019372) | 5.07002824 |
| 25 | regulation of fatty acid oxidation (GO:0046320) | 5.03609404 |
| 26 | regulation of memory T cell differentiation (GO:0043380) | 4.99264894 |
| 27 | intestinal epithelial cell development (GO:0060576) | 4.88543414 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 4.88496404 |
| 29 | interkinetic nuclear migration (GO:0022027) | 4.86816409 |
| 30 | negative regulation of fatty acid transport (GO:2000192) | 4.81089061 |
| 31 | negative regulation of complement activation (GO:0045916) | 4.79881083 |
| 32 | endothelial cell chemotaxis (GO:0035767) | 4.57293633 |
| 33 | amine catabolic process (GO:0009310) | 4.49371329 |
| 34 | cellular biogenic amine catabolic process (GO:0042402) | 4.49371329 |
| 35 | pre-miRNA processing (GO:0031054) | 4.45951232 |
| 36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.43202511 |
| 37 | quaternary ammonium group transport (GO:0015697) | 4.26989010 |
| 38 | lung vasculature development (GO:0060426) | 4.25614570 |
| 39 | negative regulation of protein activation cascade (GO:2000258) | 4.25072985 |
| 40 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.24345560 |
| 41 | regulation of keratinocyte differentiation (GO:0045616) | 4.14359757 |
| 42 | carnitine transmembrane transport (GO:1902603) | 4.14184431 |
| 43 | mannose metabolic process (GO:0006013) | 4.10485609 |
| 44 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.09229054 |
| 45 | polyamine biosynthetic process (GO:0006596) | 4.09024040 |
| 46 | diterpenoid biosynthetic process (GO:0016102) | 3.96879509 |
| 47 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.95421648 |
| 48 | homocysteine metabolic process (GO:0050667) | 3.89361395 |
| 49 | regulation of T cell cytokine production (GO:0002724) | 3.86094067 |
| 50 | import into cell (GO:0098657) | 3.84523851 |
| 51 | histone H3-K9 demethylation (GO:0033169) | 3.82079209 |
| 52 | organic cation transport (GO:0015695) | 3.79375261 |
| 53 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.78649528 |
| 54 | carnitine transport (GO:0015879) | 3.78298589 |
| 55 | amino-acid betaine transport (GO:0015838) | 3.78298589 |
| 56 | negative regulation of humoral immune response (GO:0002921) | 3.75261200 |
| 57 | GDP-mannose metabolic process (GO:0019673) | 3.70564834 |
| 58 | histone lysine demethylation (GO:0070076) | 3.70320706 |
| 59 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.64100366 |
| 60 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.63734377 |
| 61 | iron ion import (GO:0097286) | 3.63461599 |
| 62 | negative regulation of glial cell proliferation (GO:0060253) | 3.57445211 |
| 63 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.53199310 |
| 64 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.52154370 |
| 65 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.48719337 |
| 66 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.47272961 |
| 67 | positive regulation of fatty acid oxidation (GO:0046321) | 3.44013154 |
| 68 | histone demethylation (GO:0016577) | 3.42648864 |
| 69 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.35243861 |
| 70 | response to hepatocyte growth factor (GO:0035728) | 3.35243861 |
| 71 | phospholipid scrambling (GO:0017121) | 3.28495600 |
| 72 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.25854210 |
| 73 | steroid hormone mediated signaling pathway (GO:0043401) | 3.25434480 |
| 74 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.24163871 |
| 75 | protein homotrimerization (GO:0070207) | 3.19736993 |
| 76 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 3.18527995 |
| 77 | lung epithelium development (GO:0060428) | 3.15459545 |
| 78 | protein dealkylation (GO:0008214) | 3.09810003 |
| 79 | protein demethylation (GO:0006482) | 3.09810003 |
| 80 | retinol metabolic process (GO:0042572) | 3.08612122 |
| 81 | regulation of protein localization to cell surface (GO:2000008) | 3.05052136 |
| 82 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.04004829 |
| 83 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.98531465 |
| 84 | temperature homeostasis (GO:0001659) | 2.97064050 |
| 85 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.95517154 |
| 86 | cellular sodium ion homeostasis (GO:0006883) | 2.93698903 |
| 87 | positive regulation of protein kinase C signaling (GO:0090037) | 2.93195989 |
| 88 | negative regulation of multicellular organism growth (GO:0040015) | 2.93113140 |
| 89 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 2.91663214 |
| 90 | extracellular negative regulation of signal transduction (GO:1900116) | 2.90601402 |
| 91 | extracellular regulation of signal transduction (GO:1900115) | 2.90601402 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 2.88291660 |
| 93 | response to fatty acid (GO:0070542) | 2.88121485 |
| 94 | positive regulation of cation channel activity (GO:2001259) | 2.86519927 |
| 95 | endocardial cushion development (GO:0003197) | 2.86025644 |
| 96 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.85699490 |
| 97 | positive regulation of glycolytic process (GO:0045821) | 2.85335782 |
| 98 | amine biosynthetic process (GO:0009309) | 2.85038579 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.84696083 |
| 100 | skin morphogenesis (GO:0043589) | 2.84174318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.33526560 |
| 2 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 3.79350585 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.89405102 |
| 4 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.82996699 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.71084713 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.68528179 |
| 7 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.65184401 |
| 8 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.34931811 |
| 9 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 2.14988659 |
| 10 | TBL1_22424771_ChIP-Seq_293T_Human | 2.13596127 |
| 11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.11948109 |
| 12 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 2.10789490 |
| 13 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.06145695 |
| 14 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 2.02406203 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.01945192 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.97620854 |
| 17 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.97191848 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.96301005 |
| 19 | NFYA_21822215_ChIP-Seq_K562_Human | 1.94644178 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.94435505 |
| 21 | CBP_21632823_ChIP-Seq_H3396_Human | 1.90681177 |
| 22 | NFYB_21822215_ChIP-Seq_K562_Human | 1.89133074 |
| 23 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.89132087 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86918293 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86130812 |
| 26 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.85576592 |
| 27 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.82178608 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.81746335 |
| 29 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.80329832 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79870260 |
| 31 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77339071 |
| 32 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76617526 |
| 33 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70586973 |
| 34 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.70319619 |
| 35 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.69152552 |
| 36 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.67837499 |
| 37 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.66370994 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65360557 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.63274914 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63197719 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62765110 |
| 42 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.58834322 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58347932 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.57407397 |
| 45 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.55526873 |
| 46 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.48564699 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47435285 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46775965 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42512630 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41654653 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37777930 |
| 52 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37267236 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37267236 |
| 54 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35037573 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34289391 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33751680 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32709454 |
| 58 | SA1_27219007_Chip-Seq_Bcells_Human | 1.32254993 |
| 59 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30610059 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27785437 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23672104 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.19883638 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19258378 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17355605 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17355605 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16377624 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16014434 |
| 68 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.15425643 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15057140 |
| 70 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14879550 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13167573 |
| 72 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11730519 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08668855 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.08508135 |
| 75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08447576 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07997180 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.07292809 |
| 78 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.07212665 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07033594 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05659847 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05520711 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04900396 |
| 83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03847562 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01437349 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00766923 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00169104 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98256934 |
| 88 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98256934 |
| 89 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97124577 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96282498 |
| 91 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.93446599 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93266412 |
| 93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93065314 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91646057 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91630609 |
| 96 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.91430430 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.91155261 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90711037 |
| 99 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90438994 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.90363006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 6.50824402 |
| 2 | MP0003011_delayed_dark_adaptation | 6.29551224 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 5.05485129 |
| 4 | MP0008057_abnormal_DNA_replication | 4.50915282 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.50829201 |
| 6 | MP0003045_fibrosis | 3.48606733 |
| 7 | MP0004858_abnormal_nervous_system | 3.36936158 |
| 8 | MP0001188_hyperpigmentation | 2.59300274 |
| 9 | MP0002822_catalepsy | 2.54575634 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.52926119 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.38063220 |
| 12 | MP0001756_abnormal_urination | 2.37850313 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.30778169 |
| 14 | MP0004947_skin_inflammation | 2.16670822 |
| 15 | MP0003136_yellow_coat_color | 2.16528293 |
| 16 | MP0005670_abnormal_white_adipose | 2.10286344 |
| 17 | MP0000685_abnormal_immune_system | 2.07900128 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.07700934 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.01438439 |
| 20 | MP0009840_abnormal_foam_cell | 1.98503967 |
| 21 | MP0001542_abnormal_bone_strength | 1.86592913 |
| 22 | MP0003646_muscle_fatigue | 1.76466221 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.75626672 |
| 24 | MP0005310_abnormal_salivary_gland | 1.70373353 |
| 25 | MP0000383_abnormal_hair_follicle | 1.68754235 |
| 26 | MP0001765_abnormal_ion_homeostasis | 1.65586374 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.65031142 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.63133299 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.62145589 |
| 30 | MP0005595_abnormal_vascular_smooth | 1.61074984 |
| 31 | MP0002168_other_aberrant_phenotype | 1.58793139 |
| 32 | MP0004883_abnormal_blood_vessel | 1.52026813 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.48370234 |
| 34 | MP0002933_joint_inflammation | 1.40752364 |
| 35 | MP0000230_abnormal_systemic_arterial | 1.35578162 |
| 36 | MP0005395_other_phenotype | 1.28532981 |
| 37 | MP0005332_abnormal_amino_acid | 1.27342044 |
| 38 | MP0003879_abnormal_hair_cell | 1.22711161 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.21038349 |
| 40 | MP0000249_abnormal_blood_vessel | 1.17896207 |
| 41 | MP0001346_abnormal_lacrimal_gland | 1.16079576 |
| 42 | MP0001879_abnormal_lymphatic_vessel | 1.14770780 |
| 43 | MP0005620_abnormal_muscle_contractility | 1.13008017 |
| 44 | MP0005248_abnormal_Harderian_gland | 1.07440053 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.07407731 |
| 46 | MP0003828_pulmonary_edema | 1.05222858 |
| 47 | MP0004043_abnormal_pH_regulation | 1.05005161 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.03575926 |
| 49 | MP0000371_diluted_coat_color | 1.02484084 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.02083956 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.00844951 |
| 52 | MP0002136_abnormal_kidney_physiology | 0.99315058 |
| 53 | MP0002733_abnormal_thermal_nociception | 0.97651469 |
| 54 | MP0003718_maternal_effect | 0.97499255 |
| 55 | MP0000569_abnormal_digit_pigmentation | 0.96859167 |
| 56 | MP0000566_synostosis | 0.96214769 |
| 57 | MP0002928_abnormal_bile_duct | 0.94807308 |
| 58 | MP0005666_abnormal_adipose_tissue | 0.91049460 |
| 59 | MP0002736_abnormal_nociception_after | 0.90850232 |
| 60 | MP0005164_abnormal_response_to | 0.89153542 |
| 61 | MP0001727_abnormal_embryo_implantation | 0.86338230 |
| 62 | MP0005174_abnormal_tail_pigmentation | 0.86215749 |
| 63 | MP0000538_abnormal_urinary_bladder | 0.82061471 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.82041011 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.80386094 |
| 66 | MP0000367_abnormal_coat/_hair | 0.79598502 |
| 67 | MP0002405_respiratory_system_inflammati | 0.79303117 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.78868858 |
| 69 | MP0002693_abnormal_pancreas_physiology | 0.75115126 |
| 70 | MP0002075_abnormal_coat/hair_pigmentati | 0.70553901 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 0.70506544 |
| 72 | MP0003091_abnormal_cell_migration | 0.67712702 |
| 73 | MP0002972_abnormal_cardiac_muscle | 0.66326618 |
| 74 | MP0005253_abnormal_eye_physiology | 0.66196612 |
| 75 | MP0001664_abnormal_digestion | 0.65673854 |
| 76 | MP0005408_hypopigmentation | 0.65195367 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.64694095 |
| 78 | MP0001731_abnormal_postnatal_growth | 0.63139324 |
| 79 | MP0010155_abnormal_intestine_physiology | 0.61911815 |
| 80 | MP0001970_abnormal_pain_threshold | 0.61196493 |
| 81 | MP0005409_darkened_coat_color | 0.60171829 |
| 82 | MP0004885_abnormal_endolymph | 0.59906673 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.59876644 |
| 84 | MP0001186_pigmentation_phenotype | 0.59330162 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.59244036 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.58733758 |
| 87 | MP0005621_abnormal_cell_physiology | 0.58700679 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.58339011 |
| 89 | MP0003953_abnormal_hormone_level | 0.58107549 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.56868620 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.55317450 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.55233733 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.54692595 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.52746121 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52177263 |
| 96 | MP0004085_abnormal_heartbeat | 0.51036195 |
| 97 | MP0003195_calcinosis | 0.50385271 |
| 98 | MP0000613_abnormal_salivary_gland | 0.49028598 |
| 99 | MP0000749_muscle_degeneration | 0.48122801 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.47802378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoplasia of the pons (HP:0012110) | 5.84808567 |
| 2 | Nuclear cataract (HP:0100018) | 5.59736759 |
| 3 | Papilledema (HP:0001085) | 5.58735070 |
| 4 | Abnormality of the pons (HP:0007361) | 5.50551226 |
| 5 | Genetic anticipation (HP:0003743) | 5.44762550 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 5.35752370 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.75773857 |
| 8 | Dysmetric saccades (HP:0000641) | 4.35204313 |
| 9 | Neoplasm of the tracheobronchial system (HP:0100552) | 4.29879369 |
| 10 | Abnormality of homocysteine metabolism (HP:0010919) | 3.98416962 |
| 11 | Homocystinuria (HP:0002156) | 3.98416962 |
| 12 | Stomach cancer (HP:0012126) | 3.98414758 |
| 13 | Cerebellar dysplasia (HP:0007033) | 3.50862761 |
| 14 | Dysdiadochokinesis (HP:0002075) | 3.50825678 |
| 15 | Prostate neoplasm (HP:0100787) | 3.48901532 |
| 16 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.41512915 |
| 17 | Impaired smooth pursuit (HP:0007772) | 3.36630538 |
| 18 | Myokymia (HP:0002411) | 3.31149220 |
| 19 | Biconcave vertebral bodies (HP:0004586) | 3.24317944 |
| 20 | Clumsiness (HP:0002312) | 3.22098661 |
| 21 | Generalized hypopigmentation of hair (HP:0011358) | 3.21467950 |
| 22 | Lip pit (HP:0100267) | 3.19334574 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.06439810 |
| 24 | Abnormality of proline metabolism (HP:0010907) | 3.06266860 |
| 25 | Hydroxyprolinuria (HP:0003080) | 3.06266860 |
| 26 | Amelogenesis imperfecta (HP:0000705) | 3.02806910 |
| 27 | Hypoalbuminemia (HP:0003073) | 2.95300367 |
| 28 | Abnormal albumin level (HP:0012116) | 2.95300367 |
| 29 | Tubular atrophy (HP:0000092) | 2.86066240 |
| 30 | Short nail (HP:0001799) | 2.85181552 |
| 31 | Confusion (HP:0001289) | 2.85127546 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.77249962 |
| 33 | Decreased circulating renin level (HP:0003351) | 2.71122227 |
| 34 | Tented upper lip vermilion (HP:0010804) | 2.67978341 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.64026282 |
| 36 | Limb ataxia (HP:0002070) | 2.63934529 |
| 37 | Stroke (HP:0001297) | 2.61980749 |
| 38 | Severe Myopia (HP:0011003) | 2.56828607 |
| 39 | Zonular cataract (HP:0010920) | 2.54598536 |
| 40 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.54415439 |
| 41 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.47579038 |
| 42 | Severe muscular hypotonia (HP:0006829) | 2.43490620 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43071755 |
| 44 | Impaired vibratory sensation (HP:0002495) | 2.42125415 |
| 45 | Papillary thyroid carcinoma (HP:0002895) | 2.36140045 |
| 46 | Supernumerary ribs (HP:0005815) | 2.34879602 |
| 47 | Depressed nasal tip (HP:0000437) | 2.30458672 |
| 48 | Hyperventilation (HP:0002883) | 2.29964251 |
| 49 | Polar cataract (HP:0010696) | 2.29469623 |
| 50 | Broad-based gait (HP:0002136) | 2.28497734 |
| 51 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.28415363 |
| 52 | Cone-rod dystrophy (HP:0000548) | 2.25801414 |
| 53 | Goiter (HP:0000853) | 2.23808631 |
| 54 | Rhabdomyosarcoma (HP:0002859) | 2.23733481 |
| 55 | Neoplasm of the lung (HP:0100526) | 2.23402646 |
| 56 | Broad face (HP:0000283) | 2.23065707 |
| 57 | Submucous cleft hard palate (HP:0000176) | 2.22616520 |
| 58 | Nonimmune hydrops fetalis (HP:0001790) | 2.21188578 |
| 59 | Pulmonary artery stenosis (HP:0004415) | 2.17368467 |
| 60 | Abnormality of the nasal septum (HP:0000419) | 2.17225607 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.11795992 |
| 62 | Neoplasm of striated muscle (HP:0009728) | 2.11594235 |
| 63 | Retinal detachment (HP:0000541) | 2.10624211 |
| 64 | Type II lissencephaly (HP:0007260) | 2.07505743 |
| 65 | Protruding tongue (HP:0010808) | 2.07312650 |
| 66 | Onion bulb formation (HP:0003383) | 2.06244764 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.05896471 |
| 68 | Abnormal drinking behavior (HP:0030082) | 2.03643003 |
| 69 | Polydipsia (HP:0001959) | 2.03643003 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.03413883 |
| 71 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00219661 |
| 72 | Febrile seizures (HP:0002373) | 1.99028138 |
| 73 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99014237 |
| 74 | Flat cornea (HP:0007720) | 1.98514171 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 1.97193968 |
| 76 | Aortic aneurysm (HP:0004942) | 1.96682474 |
| 77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96554855 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 1.96554855 |
| 79 | Abnormality of renin-angiotensin system (HP:0000847) | 1.94459682 |
| 80 | Metabolic alkalosis (HP:0200114) | 1.94282845 |
| 81 | Obstructive sleep apnea (HP:0002870) | 1.93044593 |
| 82 | Disproportionate tall stature (HP:0001519) | 1.92580659 |
| 83 | IgA deficiency (HP:0002720) | 1.89508462 |
| 84 | Abnormality of the fingertips (HP:0001211) | 1.88052221 |
| 85 | Large for gestational age (HP:0001520) | 1.87061349 |
| 86 | Macular degeneration (HP:0000608) | 1.85530689 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84929285 |
| 88 | Fair hair (HP:0002286) | 1.83652775 |
| 89 | Type I transferrin isoform profile (HP:0003642) | 1.83608226 |
| 90 | Abnormality of cochlea (HP:0000375) | 1.83535336 |
| 91 | Neoplasm of the respiratory system (HP:0100606) | 1.83395832 |
| 92 | Medulloblastoma (HP:0002885) | 1.83115804 |
| 93 | Tachypnea (HP:0002789) | 1.82022248 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 1.81942259 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79724790 |
| 96 | Intestinal fistula (HP:0100819) | 1.78877511 |
| 97 | Abnormality of saccadic eye movements (HP:0000570) | 1.78373398 |
| 98 | Alveolar cell carcinoma (HP:0006519) | 1.76273468 |
| 99 | Epileptic encephalopathy (HP:0200134) | 1.75907922 |
| 100 | Popliteal pterygium (HP:0009756) | 1.75530474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 4.76735937 |
| 2 | TRIB3 | 4.38777596 |
| 3 | EEF2K | 3.37333963 |
| 4 | ERN1 | 3.34685189 |
| 5 | FRK | 3.27661383 |
| 6 | SGK2 | 3.06138109 |
| 7 | PKN2 | 3.03860015 |
| 8 | MAP2K6 | 2.97806160 |
| 9 | STK38L | 2.88233789 |
| 10 | TAOK1 | 2.70599414 |
| 11 | SGK223 | 2.63540362 |
| 12 | SGK494 | 2.63540362 |
| 13 | YES1 | 2.39224358 |
| 14 | SGK3 | 2.08388296 |
| 15 | MAPKAPK3 | 2.03803294 |
| 16 | PRKD3 | 2.03137689 |
| 17 | WNK1 | 2.02386941 |
| 18 | MAP3K11 | 2.01546791 |
| 19 | TAOK3 | 1.83901975 |
| 20 | TAOK2 | 1.83119325 |
| 21 | MAP3K3 | 1.80099409 |
| 22 | MKNK2 | 1.77882166 |
| 23 | PTK6 | 1.73197747 |
| 24 | MAP3K13 | 1.70206646 |
| 25 | STK38 | 1.67530818 |
| 26 | DAPK2 | 1.58597087 |
| 27 | LATS1 | 1.58555759 |
| 28 | MARK2 | 1.54157249 |
| 29 | CDK12 | 1.40764391 |
| 30 | PRKAA2 | 1.36749239 |
| 31 | NLK | 1.32920993 |
| 32 | DMPK | 1.32391692 |
| 33 | MTOR | 1.29642705 |
| 34 | EPHA3 | 1.27791008 |
| 35 | TNK2 | 1.26269017 |
| 36 | TRPM7 | 1.22469633 |
| 37 | BTK | 1.16664608 |
| 38 | CHUK | 1.12815963 |
| 39 | MAP3K7 | 1.07799545 |
| 40 | MAP2K3 | 1.05240745 |
| 41 | ITK | 1.05211771 |
| 42 | MAPK15 | 0.97968466 |
| 43 | PTK2 | 0.95789561 |
| 44 | CDC42BPA | 0.95708608 |
| 45 | STK24 | 0.95065447 |
| 46 | NEK6 | 0.93450459 |
| 47 | SGK1 | 0.90079297 |
| 48 | ERBB2 | 0.87211801 |
| 49 | TNIK | 0.83864029 |
| 50 | ACVR1B | 0.83245814 |
| 51 | HIPK2 | 0.74826415 |
| 52 | SIK1 | 0.73955058 |
| 53 | EPHB1 | 0.71797068 |
| 54 | MAPKAPK5 | 0.70242089 |
| 55 | MAP3K6 | 0.69474489 |
| 56 | MAPK13 | 0.66155622 |
| 57 | FGFR1 | 0.64948939 |
| 58 | TESK2 | 0.64787749 |
| 59 | STK3 | 0.62037930 |
| 60 | BMPR1B | 0.59889802 |
| 61 | AKT1 | 0.59872171 |
| 62 | PRKAA1 | 0.59225803 |
| 63 | PRKCZ | 0.58931144 |
| 64 | MAP3K14 | 0.54757981 |
| 65 | MKNK1 | 0.53131412 |
| 66 | BRD4 | 0.45164584 |
| 67 | MINK1 | 0.39935597 |
| 68 | MAP3K5 | 0.38983596 |
| 69 | ILK | 0.37174674 |
| 70 | PDK1 | 0.34551517 |
| 71 | CAMKK1 | 0.33644027 |
| 72 | PDGFRB | 0.32785989 |
| 73 | WNK4 | 0.31826546 |
| 74 | MAPK7 | 0.31461612 |
| 75 | RPS6KB2 | 0.31259127 |
| 76 | IRAK1 | 0.29258872 |
| 77 | MAPK12 | 0.28683769 |
| 78 | PBK | 0.28331492 |
| 79 | BRAF | 0.28131443 |
| 80 | MELK | 0.27638436 |
| 81 | CSNK1D | 0.27591611 |
| 82 | CAMK1G | 0.25935102 |
| 83 | RPS6KA3 | 0.25582731 |
| 84 | NTRK3 | 0.24409194 |
| 85 | ADRBK2 | 0.23308484 |
| 86 | GSK3A | 0.23307517 |
| 87 | MAPK1 | 0.23168094 |
| 88 | PDPK1 | 0.22611430 |
| 89 | GSK3B | 0.22562926 |
| 90 | MAPK8 | 0.21538074 |
| 91 | PRKD2 | 0.21361459 |
| 92 | CSNK1A1L | 0.20761456 |
| 93 | STK11 | 0.18926669 |
| 94 | MAPK11 | 0.18098158 |
| 95 | RET | 0.17906417 |
| 96 | MAP3K1 | 0.17286308 |
| 97 | PRKCE | 0.15196571 |
| 98 | NEK9 | 0.15102551 |
| 99 | FER | 0.14656744 |
| 100 | IKBKB | 0.14356516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 3.14489131 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.01794286 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.76024529 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50476564 |
| 5 | ABC transporters_Homo sapiens_hsa02010 | 2.49790418 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 2.44567770 |
| 7 | Insulin resistance_Homo sapiens_hsa04931 | 2.14209973 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.10898966 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.69543635 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 1.66181225 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66000882 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.62072995 |
| 13 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.61771037 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.58177434 |
| 15 | Adherens junction_Homo sapiens_hsa04520 | 1.54554380 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51279029 |
| 17 | Prostate cancer_Homo sapiens_hsa05215 | 1.48272142 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.45853362 |
| 19 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.42006941 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41138164 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 1.39452263 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.35756850 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34747652 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34722373 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29441131 |
| 26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.29154544 |
| 27 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.29052382 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22259268 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21960297 |
| 30 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.20885783 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20070881 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18309538 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14002980 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10724484 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.10679999 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09752239 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08500110 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06945391 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06231373 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05444102 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04771525 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04165228 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03999532 |
| 44 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.00410789 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00133585 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97174237 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96724813 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.96647478 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94741588 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93639778 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89989413 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 0.89390969 |
| 53 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87767070 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83093940 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79035735 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76777044 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75974781 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74727872 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74617654 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72307180 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71688343 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68798746 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67658966 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66454916 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66258893 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63604537 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.62210230 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61040248 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.59101006 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57382277 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56762591 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.56016232 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55747364 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53629420 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52727495 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52026950 |
| 77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51143871 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51112778 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50382279 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48083714 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47589555 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47555414 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45436353 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44288514 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43568965 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43545787 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43268698 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43244962 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42203415 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42070149 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42004906 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40353478 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40107446 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39362317 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39291346 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.38366665 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.38340500 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36347206 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32663865 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32328030 |

